Intrathymic injection of lentiviral vector curtails the immune response in the periphery of normal mice.
BACKGROUND
Gene transfer in the thymus, based on HIV-derived lentiviral vectors, is a promising avenue for modulation of T cell selection and autoimmunity. However, the impact of intrathymic (IT) injections on an antigen-specific immune response elicited in the periphery of normal mice has not been investigated yet.


METHODS
Highly concentrated stocks of lentiviral vectors expressing the soluble form of hemaglutinin of the influenza virus (LvHA) were injected in the thymus of normal BALB/c mice. The CD4 and CD8-mediated immune responses to HA after peripheral immunization were measured by various parameters.


RESULTS
We first show that a lentiviral vector expressing the luciferase was detected for at least 2 months after IT-injections. We then show that the LvHA vector could elicit a functional CD4- and CD8-T cell-mediated immune responses in the peripheral lymphoid organs of BALB/c mice. IT-injection of the LvHA vector significantly curbed this response: lower numbers of transferred HA-specific CD4(+) T cells were found in LvHA-injected compared to control animals. Furthermore, lower frequencies of HA-specific CD8(+) T cells, interferon γ-producing cells and cytotoxic cells were detected from 3 weeks to 3 months in LvHA-injected mice compared to controls. However, these reduced CD8-mediated responses were not increased after depletion of CD25(+) cells in vitro or in vivo.


CONCLUSIONS
The results obtained in the present study show that injection of the LvHA lentiviral vector significantly curtailed the immune response to the same antigen in the periphery. Increased selection of HA-specific regulatory T cells and negative selection of HA-specific CD8(+) T cell precursors may explain the results. Our work establish the feasibility of IT-injections of lentiviral vectors to manipulate T cell tolerance in the thymus of normal mice, for basic and pre-clinical research.
Université Pierre et Marie Curie, UPMC University of Paris 06, Paris, France.
Gaëlle
G
Gottrand
Kahina
K
Taleb
Isabelle
I
Ragon
Anne-Sophie
AS
Bergot
Jérémie D
JD
Goldstein
Gilles
G
Marodon
D000818:Animals; D058501:Enzyme-Linked Immunospot Assay; D005434:Flow Cytometry; D005452:Fluoresceins; D005822:Genetic Vectors / Q000008:administration & dosage; D019267:Hemagglutinin Glycoproteins, Influenza Virus / Q000008:administration & dosage* / Q000276:immunology*; D007111:Immunity, Cellular / Q000276:immunology*; D007267:Injections; D016086:Lentivirus; D008163:Luminescent Measurements; D051379:Mice; D008807:Mice, Inbred BALB C; D013388:Succinimides; D013950:Thymus Gland / Q000276:immunology / Q000378:metabolism*
C087165:5-(6)-carboxyfluorescein diacetate succinimidyl ester; D005452:Fluoresceins; D019267:Hemagglutinin Glycoproteins, Influenza Virus; D013388:Succinimides